Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

237 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Antiretroviral monotherapy in early stage human immunodeficiency virus disease has no detectable effect on virus load in peripheral blood and lymph nodes.
Cohen OJ, Pantaleo G, Holodniy M, Fox CH, Orenstein JM, Schnittman S, Niu M, Graziosi C, Pavlakis GN, Lalezari J, Bartlett JA, Steigbigel RT, Cohn J, Novak R, McMahon D, Bilello J, Fauci AS. Cohen OJ, et al. Among authors: fox ch. J Infect Dis. 1996 Apr;173(4):849-56. doi: 10.1093/infdis/173.4.849. J Infect Dis. 1996. PMID: 8603962 Clinical Trial.
Heterozygosity for a defective gene for CC chemokine receptor 5 is not the sole determinant for the immunologic and virologic phenotype of HIV-infected long-term nonprogressors.
Cohen OJ, Vaccarezza M, Lam GK, Baird BF, Wildt K, Murphy PM, Zimmerman PA, Nutman TB, Fox CH, Hoover S, Adelsberger J, Baseler M, Arthos J, Davey RT Jr, Dewar RL, Metcalf J, Schwartzentruber DJ, Orenstein JM, Buchbinder S, Saah AJ, Detels R, Phair J, Rinaldo C, Margolick JB, Pantaleo G, Fauci AS. Cohen OJ, et al. Among authors: fox ch. J Clin Invest. 1997 Sep 15;100(6):1581-9. doi: 10.1172/JCI119682. J Clin Invest. 1997. PMID: 9294127 Free PMC article.
Evaluation of lymph node virus burden in human immunodeficiency virus-infected patients receiving efavirenz-based protease inhibitor--sparing highly active antiretroviral therapy.
Dybul M, Chun TW, Ward DJ, Hertogs K, Larder B, Fox CH, Orenstein JM, Baird BF, Li Y, Green LG, Engel D, Liu S, Mican JM, Fauci AS. Dybul M, et al. Among authors: fox ch. J Infect Dis. 2000 Apr;181(4):1273-9. doi: 10.1086/315407. J Infect Dis. 2000. PMID: 10836864 Clinical Trial.
237 results